Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : The Nordic-Baltic Bifurcation Study IV
Kumsars, Indulis; Holm, Niels Ramsing; Niemelä, Matti; Erglis, Andrejs; Kervinen, Kari; Christiansen, Evald Høj; Maeng, Michael; Dombrovskis, Andis; Abraitis, Vytautas; Kibarskis, Aleksandras; Trovik, Thor; Latkovskis, Gustavs; Sondore, Dace; Narbute, Inga; Terkelsen, Christian Juhl; Eskola, Markku; Romppanen, Hannu; Laine, Mika; Jensen, Lisette Okkels; Pietila, Mikko; Gunnes, Pål; Hebsgaard, Lasse; Frobert, Ole; Calais, Fredrik; Hartikainen, Juha; Aarøe, Jens; Ravkilde, Jan; Engstrøm, Thomas; Steigen, Terje K.; Thuesen, Leif; Lassen, Jens F. (2020-01-19)
Kumsars, Indulis
Holm, Niels Ramsing
Niemelä, Matti
Erglis, Andrejs
Kervinen, Kari
Christiansen, Evald Høj
Maeng, Michael
Dombrovskis, Andis
Abraitis, Vytautas
Kibarskis, Aleksandras
Trovik, Thor
Latkovskis, Gustavs
Sondore, Dace
Narbute, Inga
Terkelsen, Christian Juhl
Eskola, Markku
Romppanen, Hannu
Laine, Mika
Jensen, Lisette Okkels
Pietila, Mikko
Gunnes, Pål
Hebsgaard, Lasse
Frobert, Ole
Calais, Fredrik
Hartikainen, Juha
Aarøe, Jens
Ravkilde, Jan
Engstrøm, Thomas
Steigen, Terje K.
Thuesen, Leif
Lassen, Jens F.
19.01.2020
e000947
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202101181419
https://urn.fi/URN:NBN:fi:tuni-202101181419
Kuvaus
Peer reviewed
Tiivistelmä
Background It is still uncertain whether coronary bifurcations with lesions involving a large side branch (SB) should be treated by stenting the main vessel and provisional stenting of the SB (simple) or by routine two-stent techniques (complex). We aimed to compare clinical outcome after treatment of lesions in large bifurcations by simple or complex stent implantation. Methods The study was a randomised, superiority trial. Enrolment required a SB≥2.75 mm, ≥50% diameter stenosis in both vessels, and allowed SB lesion length up to 15 mm. The primary endpoint was a composite of cardiac death, non-procedural myocardial infarction and target lesion revascularisation at 6 months. Two-year clinical follow-up was included in this primary reporting due to lower than expected event rates. Results A total of 450 patients were assigned to simple stenting (n=221) or complex stenting (n=229) in 14 Nordic and Baltic centres. Two-year follow-up was available in 218 (98.6%) and 228 (99.5%) patients, respectively. The primary endpoint of major adverse cardiac events (MACE) at 6 months was 5.5% vs 2.2% (risk differences 3.2%, 95% CI -0.2 to 6.8, p=0.07) and at 2 years 12.9% vs 8.4% (HR 0.63, 95% CI 0.35 to 1.13, p=0.12) after simple versus complex treatment. In the subgroup treated by newer generation drug-eluting stents, MACE was 12.0% vs 5.6% (HR 0.45, 95% CI 0.17 to 1.17, p=0.10) after simple versus complex treatment. Conclusion In the treatment of bifurcation lesions involving a large SB with ostial stenosis, routine two-stent techniques did not improve outcome significantly compared with treatment by the simpler main vessel stenting technique after 2 years. Trial registration number NCT01496638.
Kokoelmat
- TUNICRIS-julkaisut [19767]